ASTRAZENECA PLC

AZN
Delayed Quote. Delayed  - 10/22 11:35:02 am
8996GBX +1.50%

Turn to zoom
Prev.8863.0000
Open8892.0000
High9029.0000
Low8873.0000
Volume938 028
Latest news
2h ago
7h ago
12h ago
1d ago
Chart ASTRAZENECA PLC
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishBullishBullish
Resistance9 0039 0039 861
Spread/Res.-0,08%-0,08%-8,8%
Spread/Supp.6,2%12%12%
Support8 4748 0638 063
Financials
Sales 2021 35 441 M - -
Net income 2021 4 862 M - -
Net Debt 2021 24 847 M - -
P/E ratio 2021 26,0x
Yield 2021 3,13%
Capitalization 139 B 192 B -
EV / Sales 2021 4,63x
EV / Sales 2022 3,72x
Nbr of Employees 76 100
Free-Float 96,4%
Company
AstraZeneca PLC is a biopharmaceutical company. It focuses on discovery and development of products, which are then manufactured, marketed and sold. It focuses on three main therapy areas: Oncology, Cardiovascular, Renal & Metabolic (CVRM) and Respiratory, while selectively pursuing therapies in...

>> Read more
Sector :
Other Pharmaceuticals
Calendar :
2021-11-12 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 27
Last Close Price 89,96 $
Average target price 137,81 $
Spread / Average Target 53,2%